Cargando…
Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden
BACKGROUND: The World Health Organization has set a goal to reach world elimination of hepatitis C virus (HCV) by 2030. Needle and syringe programs (NSP) for people who inject drugs (PWID) are crucial to achieve this goal. The NSP in Uppsala, Sweden, was opened in 2016 and has since 2018 provided HC...
Autores principales: | Kågström, E., Lannergård, A., El Khosht, J., Lörelius, P., Månflod, J., Strömdahl, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273738/ https://www.ncbi.nlm.nih.gov/pubmed/37328868 http://dx.doi.org/10.1186/s12954-023-00806-w |
Ejemplares similares
-
Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden
por: Kåberg, Martin, et al.
Publicado: (2022) -
Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden
por: Lindqvist, K., et al.
Publicado: (2023) -
Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan
por: Zule, William A., et al.
Publicado: (2015) -
Effectiveness of needle and syringe Programmes in people who inject drugs – An overview of systematic reviews
por: Fernandes, Ricardo M, et al.
Publicado: (2017) -
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
por: Platt, Lucy, et al.
Publicado: (2017)